[company_age]unknown[/company_age][employees]10,001+ employees[/employees][funding]Post IPO debt[/funding][description]AstraZeneca is a global biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. The company also has a strong presence in Vaccines & Immune Therapies and Rare Diseases. AstraZeneca is committed to delivering life-changing medicines that make a meaningful difference to patients worldwide. The company has a long history of innovation, dating back to its founding in 1913. AstraZeneca has a strong track record of scientific discovery and development, with a pipeline of innovative medicines that address some of the world's most pressing healthcare challenges. The company is also committed to sustainability and ethical business practices. AstraZeneca is a member of the FTSE 100 Index and is headquartered in Cambridge, UK.[/description][ps]Prescription medicines, vaccines, and immune therapies[/ps]